Bio-Rad Q2 2025: Strong Growth & Raised Guidance episode artwork

EPISODE · May 4, 2026 · 2 MIN

Bio-Rad Q2 2025: Strong Growth & Raised Guidance

from The Daily News Now! Business

Bio-Rads Q2 2025 earnings beat expectations with $652 million in sales, up 2.1% year-over-year, driven by strong process chromatography in life sciences. Operating margins hit 13.6% non-GAAP, despite headwinds. Life sciences saw a 4.7% increase, while diagnostics held steady. Consumables like droplet digital PCR showed high single-digit gains. The company raised full-year guidance, with process chromatography outlook at low double-digits and ddPCR mid-single-digit growth. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/764a6dd77084867b

NOW PLAYING

Bio-Rad Q2 2025: Strong Growth & Raised Guidance

0:00 2:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on May 4, 2026.

What is this episode about?

Bio-Rads Q2 2025 earnings beat expectations with $652 million in sales, up 2.1% year-over-year, driven by strong process chromatography in life sciences. Operating margins hit 13.6% non-GAAP, despite headwinds. Life sciences saw a 4.7%...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!